With the aim of being the largest life sector by 2035 behind only the US and China, the UK government is ramping up commercialisation.

Bio-Techne has announced a collaboration to distribute Spear Bio’s advanced SPEAR UltraDetect immunoassays globally.

Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours.